Consistent with the fact that NT-ProBNP serves as a strong predictive factor of heart failure events in patients with HFpEF (19), we discovered that the level of NT-ProBNP in rats serum with HFpEF decreased significantly by the treatment of ePLM. This evidence concerns the gene NPPB and heart failure.